FDA Inspection 1288412 — Eurofins BioPharma Product Testing Hamburg GmbH
The FDA completed an inspection of Eurofins BioPharma Product Testing Hamburg GmbH on October 19, 2022 in Hamburg. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). Product area: Drugs.
Inspection Details
- Classification
- Voluntary Action Indicated (VAI) (VAI)
- End Date
- October 19, 2022
- Fiscal Year
- 2023
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Hamburg (Germany)
Additional Details
Mutual Recognition Agreement (MRA)